Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Biostimulanter Sverige AB
AB
Dissolved
Org 5592317480
Wholesale of grain, unmanufactured tobacco, seeds and animal feeds · NACE 4621
Est. 2019
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2021
SEK 1,3M
-23% vs 2020
EBITDA margin
14.6%
+37% vs 2020
Equity ratio
37.5%
Financial strength
Net profit 2021
SEK 101K
+44% vs 2020
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
SEK 1,3M
-23%
EBITDA
SEK 186K
+37%
Net profit
SEK 101K
+44%
Total assets
SEK 722K
-9%
Equity
SEK 271K
+59%
Employees
0
—
Company information
Legal name
Biostimulanter Sverige AB
Org number
5592317480
Legal form
Aktiebolag
NACE code
4621 · Wholesale of grain, unmanufactured tobacco, seeds and animal feeds
Founded
13 december 2019
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Utveckling och försäljning av biostimulanter till den gröna näringen i Sverige, handel med värdepapper samt därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of grain, unmanufactured tobacco, seeds and animal feeds
Companies in
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2020
1M
2021
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
Income statement
SEK thousands
Item
2020
2021
Revenue
1 648
1 274
Staff expenses
—
—
EBITDA
136
186
Depreciation & amort.
−12
−16
EBIT
124
170
Net financials
—
—
Profit before tax
92
128
Tax
−22
−27
Net profit
70
101
Balance sheet
SEK thousands
Item
2020
2021
Total assets
795
722
Equity
170
271
Long-term debt
545
46
Short-term debt
48
329
Total debt
593
375
Financial ratios
5-year trend
EBITDA margin
14.6%
This company
15.8%
Market median
-8% vs market
2020
2021
Equity ratio
37.5%
This company
38.2%
Market median
+2% vs market
2020
2021
Return on equity
37.3%
This company
18.4%
Market median
+103% vs market
2020
2021
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
2020
2021
Asset turnover
1.76×
This company
1.12×
Market median
+57% vs market
2020
2021
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
2020
2021
Annual reports & filings
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
OM
Olle Magnus Ryegård
Board of Directors
2022
SM
Svante Mattias Kaijser
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Biostimulanter Sverige AB also hold positions in
0
other companies.
Person
Role here
Other companies
Olle Magnus Ryegård
Board of Directors
0 companies
Svante Mattias Kaijser
Deputy Board Member
0 companies